Enzolytics’ IPF Immune™ Provides a Comprehensive Natural Solution for Supporting Normal Immune Function
Industry: Health & Fitness
Americans Search for Dietary Supplements to Boost Their Health
Boca Raton, FL (PRUnderground) February 6th, 2023
Enzolytics, Inc. is expanding its retail distribution network in the coming months for IPF Immune™, a dietary supplement for people who want to take a proactive approach to support their body’s natural immune system.
“IPF Immune™ is an incredible, natural, proprietary formula backed by science,” said Charles S. Cotropia, CEO of Enzolytics, Inc., a Texas-based biotech company. “Our patented technology is a unique formulation that supports normal immune function.”
Enzolytics, which is committed to developing effective and affordable therapeutics for treating a variety of conditions, is launching IPF Immune™ in the United States just as a record number of consumers are taking dietary supplements.
Mr. Cotropia said IPF Immune™ is produced in cGMP-certified manufacturing facilities with state-of-the-art production equipment to ensure the best healthy ingredients.
“Our research team took every precaution to develop the highest-quality immune support supplement,” he added. “When you buy IPF Immune™, you can be confident that you are getting a patented formulation designed to support your body’s natural immune function.”
Harry H. Zhabilov, Enzolytics’ Chief Scientific Officer, said IPF Immune™ is also gluten-and-GMO-free.
“Our immune system is vital to keeping us healthy,” Mr. Zhabilov said. “When our bodies come in contact with a virus, our immune system activates to fight against them. IPF Immune™ is a patented formula that is designed to help keep your immune system in tip-top condition, ready to quickly and efficiently keep you healthy and feeling good.”
IPF Immune™ is currently available on OneLavi.com, a boutique, health, and wellness website.
“We expect IPF Immune™ to be on Walmart.com in the coming weeks,” Mr. Cotropia said. “We also have a marketing campaign planned to promote IPF Immune™ to consumers through strategic press releases, outreach to media, and national TV tagging campaigns.“
For more information, email firstname.lastname@example.org or visit enzolytics.com.
Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Enzolytics, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.
1101 Raintree Circle
Allen, Texas 75013
Texas A&M University
Institute for Preclinical Studies
College Station, TX 77843-44
SOURCE: Enzolytics, Inc.
About Enzolytics, Inc.
Enzolytics Inc. is a Texas-based biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to Enzolytics IPF Immune™, which will be on the U.S. market soon, the Company is developing other therapeutics for treating multiple infectious diseases.